financetom
Market
financetom
/
Market
/
Rural demand will take time to return; bullish on TCS, L&T Tech: Saurabh Mukherjee
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rural demand will take time to return; bullish on TCS, L&T Tech: Saurabh Mukherjee
Feb 10, 2022 4:38 AM

Saurabh Mukherjea, Founder, Marcellus Investment Managers, on Thursday, mentioned that demand challenge faced by rural India will take some time to go away. He expects the next 3 quarters to be slow on the rural consumption front.

Share Market Live

NSE

"It has been said by almost every fast moving consumer goods (FMCG) company and every two-wheeler company that there is a demand challenge in rural India. It will take time to go away. We need normalization of the labor market, as COVID hopefully abates now. There could be one or two soft quarters, perhaps three soft quarters - the third quarter hence will be driven away by the monsoon," he said.

In the IT sector, Mukherjea likes L&T Technology Services due to its focus on engineering and research and development (R&D). He also mentioned that he is bullish on TCS.

"Among consistent compounders, Tata Consultancy Services (TCS) is our main investment. In our midcap portfolio on rising giants, we have L&T Technology Services, which is a very niche player. It's actually more a play on engineering and R&D than it is on IT services," he added.

Also Read:

No plan to merge Vedanta Resources with Vedanta, says Anil Agarwal; delisting not on the cards

In the pharma space, he mentioned that they own just Divi’s Laboratories. He explained the rationale behind owning the stock. He said that the company’s results have been consistent over the last 20 years and hence, they are invested in it.

"Barring Divi’s Laboratories, we don't have any pharma company which is a play on global pharma, and Divi’s Laboratories supplies active pharmaceutical ingredient (API) to the global giants, it doesn't sell anything in India. It's a completely export-driven story. If you see 20 years of numbers for Divi’s, if you see their profit margins and the return on capital (ROC) over 20 years, there isn't that much volatility," he said.

On new-age business stocks like Nykaa, he believes there's a need to focus on business growth and not the stock price.

"I wouldn't lose too much sleep if I was a holder. The share price doesn't tell you anything. Whether the share price has gone up or down, it's a completely meaningless signal. What shareholders of these companies or those looking at these companies need to assess is- do these companies have barriers to entry," he explained.

"So does Nykaa have barriers to entry? Does Nykaa have customer captivity? And if the answers to all of those are yes, then Nykaa is a good stock to buy. It is a good investment and it will make you money. The point I'm trying to convey is that the stock price doesn't tell the investor anything," he mentioned.

Also Read: Should you buy, sell or hold Nykaa shares after Q3 results? Here's what brokerages recommend

In the industrial engineering space, Mukherjea mentioned that they are positive on GMM Pfaudler.

"We continued buying non-stop throughout and even this week, right now, we are continuing to buy GMM Pfaudler," he said.

Watch the video for the full interview.

Catch all stock market action here

Follow our live blog on the RBI monetary policy here

First Published:Feb 10, 2022 1:38 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved